# Arkeon

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/arkeon

- Industry: Food
- Headquarters: Vienna, Austria
- Website: www.arkeon.bio
- Total disclosed funding: $13M
- Latest round: Seed (Dec 23, 2022)
- Investors on record: 8

## About

Based in Vienna, Austria, and co-founded in 2021 by its CEO, Dr. Gregor Tegl, CSO, Dr. Simon Rittmann, and Dr. Guenther Bochmann, Arkeon GmbH operates as a biotechnology company that captures carbon dioxide from industry and converts inorganic gases into organic food. In March 2022, Arkeon GmbH raised EUR 6.5 million in seed funding from new investors, Blue Horizon Corporation, EVIG GmbH, ReGen Ventures, and Synthesis Capital.

Arkeon offers vegan-friendly, genetically modified organism (GMO)- free organic food that is made from inorganic gases through the process of fermentation. It converts carbon dioxide into amino acids, functional peptides, and single-cell proteins, which are a mixture of protein, carbohydrates, and fat.

The company plans to use the March 2022 funding to scale up production levels, process engineering, and product development. The company also plans to reach 10 billion people by 2050.

## Funding rounds

- Seed, Dec 23, 2022, $6.4M — aws Fondsmanagement, ICL, Synthesis Capital, Tet Ventures, HackVentures Ltd.
- Seed, Mar 7, 2022, $7.1M — Blue Horizon, Synthesis Capital, ReGen Ventures, EVIG GmbH

## Investors

- Blue Horizon (https://capitalatlas.ai/funds/blue-horizon) — Seed
- Synthesis Capital — Seed
- ReGen Ventures (https://capitalatlas.ai/funds/regen-ventures) — Seed
- EVIG GmbH — Seed
- aws Fondsmanagement (https://capitalatlas.ai/funds/aws-fondsmanagement) — Seed
- ICL — Seed
- Tet Ventures (https://capitalatlas.ai/funds/tet-ventures) — Seed
- HackVentures Ltd. — Seed